Umut Yücel, Oytun Erbaş

Institute of Experimental Medicine, Gebze-Kocaeli, Türkiye

Keywords: Breast cancer, hormone receptor-negative breast cancer, hormone receptor-positive breast cancer, oxytocin receptor, oxytocin, prolactin.


It has long been a challenge for modern medical research to grasp and compose a sustainable treatment plan for all the different types of breast cancer for all patients with very different backgrounds in terms of their age, menopausal status, past pregnancies, body mass index, and genetics. Estrogen and progesterone have long been recognized as prominent hormones in the classification and treatment of many types of breast cancer. This review article focuses on the potential of implementing oxytocin and prolactin as yet other forthcoming factors, whose importance has been revealed by medical research conducted more promisingly in the last few decades, for approaching the classification and treatment algorithm of breast cancer, by briefly reviewing the plethora of studies published on the topic.

Cite this article as: Yücel U, Erbaş O. The role of oxytocin and prolactin in breast carcinogenesis and breast cancer prognosis: a mini-review. D J Tx Sci 2022;7(1-2):7-13.

Author Contributions

All authors contributed equally to the article.

Data Sharing Statement:
The data that support the findings of this study are available from the corresponding author upon reasonable request.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/ or publication of this article.

Financial Disclosure

The authors received no financial support for the research and/or authorship of this article.